Prenatal diagnostic testing and Down syndrome in Victoria 1992-2002

被引:12
作者
Muggli, EE [1 ]
Halliday, JL [1 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
关键词
D O I
10.1111/j.1467-842X.2004.tb00946.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To describe patterns of uptake of prenatal diagnostic testing and prenatal detection rates for Down syndrome in Victoria with regard to maternal age and prenatal screening practices. Methods: Analysis of routinely collected statewide datasets for 1992 to 2002, containing detailed information on all prenatal diagnoses, births and birth defects. Results: Utilisation of prenatal diagnosis in women less than 37 years has increased significantly (p<0.0001), whereas in older women it has fallen from 65.1% in 1996 to 42.7% in 2002. The overall proportion of diagnostic tests prompted by an increased risk screening test result has increased five-fold over 11 years to 35.4% in 2002 (p<0.0001). Almost 6% of diagnostic tests done in 2002 detected a fetal chromosome abnormality, compared with 3.0% in 1992. Prenatal detection of Down syndrome has increased in women less than 37 years with approximately 70% of cases now diagnosed prenatally (p<0.0001). A smaller non-significant increase (from 67% to 82%) in prenatal detection of Down syndrome was observed among older women. Conclusions: The widespread use of prenatal screening for Down syndrome has changed the demographic profile of women having prenatal diagnosis in terms of their age. An increasing number and proportion of younger women and fewer older women are having prenatal diagnosis. The declining figures for diagnostic testing in older women have not had an impact on prenatal detection rates for Down syndrome. Implication: Current prenatal screening practices provide a more effective risk assessment for Down syndrome and indication for prenatal diagnosis than advanced maternal age alone.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 16 条
[1]  
ALFIREVIC Z, 2003, COCHRANE DATABASE SY
[2]   Down's syndrome: occurrence and outcome in the north of England, 1985-99 [J].
Bell, R ;
Rankin, J ;
Donaldson, LJ .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2003, 17 (01) :33-39
[3]   Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions [J].
Benn, PA .
CLINICA CHIMICA ACTA, 2002, 324 (1-2) :1-11
[4]  
Binkert F, 2002, SWISS MED WKLY, V132, P478
[5]   The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia [J].
Cheffins, T ;
Chan, A ;
Haan, EA ;
Ranieri, E ;
Ryall, RG ;
Keane, RJ ;
Byron-Scott, R ;
Scott, H ;
Gjerde, EM ;
Nguyen, AM ;
Ford, JH ;
Sykes, S .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (12) :1453-1459
[6]   Prenatal diagnosis for women aged 37 years and over: to have or not to have [J].
Halliday, JL ;
Warren, R ;
McDonald, G ;
Rice, PL ;
Bell, RJ ;
Watson, LF .
PRENATAL DIAGNOSIS, 2001, 21 (10) :842-847
[7]   FOLLOW-UP VALIDATION-STUDY OF THE VICTORIAN CONGENITAL-MALFORMATIONS REGISTER [J].
KILKENNY, M ;
RILEY, M ;
LUMLEY, J .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1995, 31 (04) :323-325
[8]  
McLennan Andrew, 2003, Aust Fam Physician, V32, P107
[9]   Validation study of the victorian birth defects register [J].
Riley, M ;
Phyland, S ;
Halliday, J .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2004, 40 (9-10) :544-548
[10]  
RILEY M, 2004, BIRTH DEFECTS VICTOR